Pfizer Pipeline: New Drugs In The Making

Physician Commentary, Psych Drugs Alzheimer's, Alzheimer's research, Alzheimer's vaccine, Dementia, Psychiatry Drugs

Pfizer Pipeline: New Drugs In The Making

(August 9, 2013) – Pfizer is in the process of developing the following new drugs that may prove very useful in the field of Psychiatry drugs:

AAC-001 (Phase 2): New Alzheimer’s disease vaccine
AAB-003 (Phase 1): New biologic Alzheimer’s treatment
SAM-760 (Phase 3): New Alzheimer’s treatment
PF-04958242 (Phase 1): New Schizophrenia treatment
Lyrica CR (Phase 3): Once daily dosing medication for chronic pain management

This is a very exciting time in the development of new psychiatric treatments, especially the thought of being able to have a vaccine to prevent Alzheimer’s disease.

By Terra C. Caudill, MD, MS